You Are Here:
Clinical Summary of U.S. Preventive Services Task Force Recommendation
This document is a summary of the 2011 recommendation of the U.S. Preventive Services Task Force on Screening for Visual Impairment in Children Ages 1 to 5. It is intended for use by primary care clinicians. This summary was first published in Pediatrics (Pediatrics 2011;127:341).
|Population||Children ages 3 to 5 years||Children younger than 3 years of age|
|Recommendation||Provide vision screening||No recommendation|
|Screening Tests||Various screening tests are used in primary care to identify visual impairment in children, including:
|Timing of Screening||No evidence was found regarding appropriate screening intervals.|
|Interventions||Primary treatment for amblyopia includes the use of corrective lenses, patching, or atropine therapy of the non-affected eye. Treatment may also consist of a combination of interventions.|
|Balance of Harms and Benefits||There is adequate evidence that early treatment of amblyopia in children ages 3 to 5 years leads to improved visual outcomes. There is limited evidence on harms of screening, including psychosocial effects, in children ages 3 years and older.
There is inadequate evidence that early treatment of amblyopia in children younger than 3 years of age leads to improved visual outcomes.
|Suggestions for Practice Regarding the I Statement||In deciding whether to refer children younger than 3 years of age for screening, clinicians should consider:
For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents, please go to http://www.uspreventiveservicestaskforce.org.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
AHRQ Publication No. 11-05151-EF-3
Current as of January 2011
U.S. Preventive Services Task Force. Screening for Visual Impairment in Children Ages 1 to 5: Clinical Summary of U.S. Preventive Services Task Force Recommendation. AHRQ Publication No. 11-05151-EF-3, January 2011. http://www.uspreventiveservicestaskforce.org/uspstf11/vischildren/vischildsum.htm